12:00 AM
May 21, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

External Trigeminal Nerve Stimulation: Phase Ib data

Researchers at the University of California, Los Angeles, reported data from an open-label, U.S. Phase Ib trial in 11 adults with non-psychotic unipolar MDD that lasted >4 months and who have not responded to >=1 antidepressant showing that nightly 8-hour treatment with eTNS significantly reduced HDRS...

Read the full 209 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >